BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29654310)

  • 1. APOBEC3-mediated restriction of RNA virus replication.
    Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
    Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
    Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.
    Minkah N; Chavez K; Shah P; Maccarthy T; Chen H; Landau N; Krug LT
    Virology; 2014 Apr; 454-455():215-26. PubMed ID: 24725948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
    Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
    PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human APOBEC3 Variations and Viral Infection.
    Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV restriction by APOBEC3 in humanized mice.
    Krisko JF; Martinez-Torres F; Foster JL; Garcia JV
    PLoS Pathog; 2013 Mar; 9(3):e1003242. PubMed ID: 23555255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Patterson AP
    J Biol Chem; 2021 Aug; 297(2):100889. PubMed ID: 34181944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo.
    Suspène R; Aynaud MM; Koch S; Pasdeloup D; Labetoulle M; Gaertner B; Vartanian JP; Meyerhans A; Wain-Hobson S
    J Virol; 2011 Aug; 85(15):7594-602. PubMed ID: 21632763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function.
    Jang GM; Annan Sudarsan AK; Shayeganmehr A; Prando Munhoz E; Lao R; Gaba A; Granadillo Rodríguez M; Love RP; Polacco BJ; Zhou Y; Krogan NJ; Kaake RM; Chelico L
    Mol Cell Proteomics; 2024 May; 23(5):100755. PubMed ID: 38548018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deaminase-Dead Mouse APOBEC3 Is an
    Stavrou S; Zhao W; Blouch K; Ross SR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
    Bonvin M; Greeve J
    Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
    Binka M; Ooms M; Steward M; Simon V
    J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
    Refsland EW; Hultquist JF; Harris RS
    PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
    Poulain F; Lejeune N; Willemart K; Gillet NA
    PLoS Pathog; 2020 Aug; 16(8):e1008718. PubMed ID: 32797103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.
    Li J; Chen Y; Li M; Carpenter MA; McDougle RM; Luengas EM; Macdonald PJ; Harris RS; Mueller JD
    J Mol Biol; 2014 Mar; 426(6):1296-307. PubMed ID: 24361275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular evolution of physiologically functioning anti-retroviral APOBEC3 deaminases].
    Miyazawa M
    Uirusu; 2012 Jun; 62(1):27-38. PubMed ID: 23189822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
    Henry M; Guétard D; Suspène R; Rusniok C; Wain-Hobson S; Vartanian JP
    PLoS One; 2009; 4(1):e4277. PubMed ID: 19169351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.